Literature DB >> 6216110

Tumor-specific T helper activity can be abrogated by two distinct suppressor cell mechanisms.

S Howie, W H McBride.   

Abstract

Tumor-specific helper T cell activity was detected in the spleens of tumor-bearing mice using a sensitive, simple and reproducible in vitro assay based on those previously described for soluble hapten-carrier antigens. Helper activity disappears when the tumor is large. This is coincident with the appearance of two distinct types of suppressor cells: (a) T cells which suppress tumor-specific T helper responses and (b) non-T cells which are nonspecific in their action.

Entities:  

Mesh:

Year:  1982        PMID: 6216110     DOI: 10.1002/eji.1830120809

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Immunoregulating activity of tumor-associated macrophages.

Authors:  G J Dougherty; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Interactions between herpes simplex virus and murine bone marrow macrophages.

Authors:  S Howie; M Norval; J Maingay; W H McBride
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 3.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

4.  Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.

Authors:  G J Dougherty; J D Thacker; R S Lavey; A Belldegrun; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

5.  Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum.

Authors:  W H McBride; S Howie
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

Review 6.  The confluence of stereotactic ablative radiotherapy and tumor immunology.

Authors:  Steven Eric Finkelstein; Robert Timmerman; William H McBride; Dörthe Schaue; Sarah E Hoffe; Constantine A Mantz; George D Wilson
Journal:  Clin Dev Immunol       Date:  2011-11-15

Review 7.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

8.  Regulatory T cells in radiotherapeutic responses.

Authors:  Dörthe Schaue; Michael W Xie; Josephine A Ratikan; William H McBride
Journal:  Front Oncol       Date:  2012-08-17       Impact factor: 6.244

9.  Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells.

Authors:  W H McBride; S E Howie
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

10.  Tumor Size Matters-Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy.

Authors:  Jean Philippe Nesseler; Mi-Heon Lee; Christine Nguyen; Anusha Kalbasi; James W Sayre; Tahmineh Romero; Philippe Nickers; William H McBride; Dörthe Schaue
Journal:  Cancers (Basel)       Date:  2020-03-18       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.